Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Foundation Medicine Inc (NASDAQ:FMI)

18.60
Delayed Data
As of 4:00pm ET
 +0.45 / +2.48%
Today’s Change
13.34
Today|||52-Week Range
25.31
+5.08%
Year-to-Date
Baron Funds Comments on Foundation Medicine
4:18pm / GuruFocus News - Paid Partner Content
Why Exact Sciences' Stock Could Go Much Higher
Jan 13 / MotleyFool.com - Paid Partner Content
What's Behind Clovis' (CLVS) One-Year Rally of 146.3%?
Jan 17 / Zacks.com - Paid Partner Content
Foundation Medicine (FMI): Moving Average Crossover Alert
Jan 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.15
Today’s open18.10
Day’s range18.00 - 18.80
Volume117,929
Average volume (3 months)159,505
Market cap$636.3M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-45.99%
Earnings growth (this year)-17.40%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.59%
P/E ratioNM
Price/Sales7.42
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
NEONeogenomics Inc+0.10+1.19%
NTRANatera Inc-0.21-2.16%
GHDXGenomic Health Inc+0.35+1.29%
NVTAInvitae Corp+0.56+7.04%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$93.2M
Annual profit (last year)-$89.6M
Net profit margin-96.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael J. Pellini
President &
Chief Operating Officer
Steven J. Kafka
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs